Home » Topics » Regulatory » Patents

Patents
RSS

Janssen Pharmaceutica discloses novel fibroblast growth factor receptor inhibitors

April 11, 2017

Pfizer discovers new beta-secretase 1 inhibitors

April 11, 2017

GlaxoSmithKline divulges novel bromodomain and extra-terminal protein inhibitors

April 11, 2017

Redx Pharma patents tyrosine-protein kinase BTK inhibitors

April 11, 2017

Assembly Biosciences, IURTC present HBV core protein modulators

April 10, 2017

Sunshine Lake Pharma, Calitor Sciences patent JAK, FLT-3 and Aurora kinase inhibitors

April 10, 2017

Merck KGaA discloses new IRAK-1/4 inhibitors

April 10, 2017

NSTDA patents dihydrofolate reductase inhibitors

April 10, 2017

Janssen identifies novel FGFR inhibitors

April 10, 2017

Indiana University Research and Technology, Assembly Biosciences present HBV core protein modulators

April 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...